|
[1] TANG A, CLOUTIER G, SZEVERENYI NM, et al. Ultrasound elastography and MR elastography for assessing liver fibrosis:Part 2, diagnostic performance, confounders, and future directions[J]. AJR Am J Roentgenol, 2015, 205 (1) :33-40.
|
|
[2] KIM YS, SONG JS, KANNENGIESSER S, et al. Comparison of spin-echo echoplanar imaging and gradient recalled echo-based MR elastography at 3 tesla with and without gadoxetic acid administration[J]. Eur Radiol, 2017, 27 (10) :4120-4128.
|
|
[3] MORISAKA H, MOTOSUGI U, GLASER KJ, et al. Comparison of diagnostic accuracies of two-and three-dimensional MR elastography of the liver[J]. J Magn Reson Imaging, 2017, 45 (4) :1163-1170.
|
|
[4] SHI Y, XIA F, LI Q, et al. Magnetic resonance elastography for the evaluation of liver fibrosis in chronic hepatitis B and C by using both gradient-recalled echo and spin-echo echo planar imaging:A prospective study[J]. Am J Gastroenterol, 2016, 111 (6) :823-833.
|
|
[5] LOOMBA R, CUI J, WOLFSON T, et al. Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD:A prospective study[J]. Am J Gastroenterol, 2016, 111 (7) :823-833.
|
|
[6] FRIEDMAN SL, BANSAL MB. Reversal of hepatic fibrosisfact or fantasy?[J]. Hepatology, 2006, 43 (1) :82-88.
|
|
[7] WANG J, MALIK N, YIN M, et al. Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis[J]. World J Gastroenterol, 2017, 23 (5) :859-868.
|
|
[8] SU LN, GUO SL, LI BX, et al. Diagnostic value of magnetic resonance elastography for detecting and staging of hepatic fibrosis:A meta-analysis[J]. Clin Radiol, 2014, 69 (12) :545-552.
|
|
[9] SINGH S, VENKATESH SK, WANG Z, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis:A systematic review and meta-analysis of individual participant data[J]. Clin Gastroenterol Hepatol, 2015, 13 (3) :440-451.
|
|
[10] WANG QB, ZHU H, LIU HL, et al. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis:A meta-analysis[J]. Hepatology, 2012, 56 (1) :239-247.
|
|
[11] SINGH S, VENKATESH SK, LOOMBA R, et al. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease:A diagnostic accuracy systematic review and individual participant data pooled analysis[J]. Eur Radiol, 2016, 26 (5) :1431-1440.
|
|
[12] GUO Y, PARTHASARATHY S, GOYAL P, et al. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis:A meta-analysis[J]. Abdom Imaging, 2015, 40 (4) :818-834.
|
|
[13] DYVORNE HA, JAJAMOVICH GH, BESA C, et al. Simultaneous measurement of hepatic and splenic stiffness using MR elastography:Preliminary experience[J]. Abdom Imaging, 2015, 40 (4) :803-809.
|
|
[14] CHOI YR, LEE JM, YOON JH, et al. Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis[J]. Invest Radiol, 2013, 48 (8) :607-613.
|
|
[15] LEITAO HS, DOBLAS S, GARTEISER P, et al. Hepatic fibrosis, inflammation, and steatosis:Influence on the MR viscoelastic and diffusion parameters in patients with chronic liver disease[J]. Radiology, 2017, 283 (1) :98-107.
|
|
[16] PARK HS, KIM YJ, YU MH, et al. Three-tesla magnetic resonance elastography for hepatic fibrosis:Comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging[J]. World J Gastroenterol, 2014, 20 (46) :17558-17567.
|
|
[17] CUI J, ANG B, HAUFE W, et al. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease:A prospective study[J]. Aliment Pharmacol Ther, 2015, 41 (12) :1271-1280.
|
|
[18] ICHIKAWA S, MOTOSUGI U, MORISAKA H, et al. Validity and reliability of magnetic resonance elastography for staging hepatic fibrosis in patients with chronic hepatitis B[J]. Magn Reson Med Sci, 2015, 14 (3) :211-221.
|
|
[19] KIM D, KIM WR, TALWALKAR JA, et al. Advanced fibrosis in nonalcoholic fatty liver disease:Noninvasive assessment with MR elastography[J]. Radiology, 2013, 268 (2) :411-419.
|
|
[20] DYVORNE HA, JAJAMOVICH GH, BANE O, et al. Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection[J]. Liver Int, 2016, 36 (5) :659-666.
|
|
[21] YANG EN, CAO WK. Research advances in noninvasive diagnosis of hepatic fibrosis[J]. J Clin Hepatol, 2017, 33 (11) :2209-2213. (in Chinese) 杨二娜, 曹武奎.肝纤维化无创诊断的研究进展[J].临床肝胆病杂志, 2017, 33 (11) :2209-2213.
|
|
[22] HUWART L, SEMPOUX C, VICAUT E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis[J]. Gastroenterology, 2008, 135 (1) :32-40.
|
|
[23] HSU C, CAUSSY C, IMAJO K, et al. Magnetic resonance vs transient elastography analysis of patients with non-alcoholic fatty liver disease:A systematic review and pooled analysis of individual participants[J]. Clin Gastroenterol Hepatol, 2019, 17 (4) :630-637. e8.
|
|
[24] PARK CC, NGUYEN P, HERNANDEZ C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease[J]. Gastroenterology, 2017, 152 (3) :598-607.
|
|
[25] IMAJO K, KESSOKU T, HONDA Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography[J]. Gastroenterology, 2016, 150 (3) :626-637.
|
|
[26] GUO Y, PARTHASARATHY S, GOYAL P, et al. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis:A meta-analysis[J]. Abdom Imaging, 2015, 40 (4) :818-834.
|
|
[27] YOON JH, LEE JM, JOO I, et al. Hepatic fibrosis:Prospective comparison of MR elastography and US shear-wave elastography for evaluation[J]. Radiology, 2014, 273 (3) :772-782.
|
|
[28] DE FR. Expanding consensus in portal hypertension:Report of the Baveno VI Consensus Workshop:Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63 (3) :743-752.
|
|
[29] SUK KT. Hepatic venous pressure gradient:Clinical use in chronic liver disease[J]. Clin Mol Hepatol, 2014, 20 (1) :6-14.
|
|
[30] NEDREDAL GI, YIN M, MCKENZIE T, et al. Portal hypertension correlates with splenic stiffness as measured with MR elastography[J]. J Magn Reson Imaging, 2011, 34 (1) :79-87.
|
|
[31] YIN M, KOLIPAKA A, WOODRUM DA, et al. Hepatic and splenic stiffness augmentation assessed with MR elastography in an in vivo porcine portal hypertension model[J]. J Magn Reson Imaging, 2013, 38 (4) :809-815.
|
|
[32] GHARIB AM, HAN M, MEISSNER EG, et al. Magnetic resonance elastography shear wave velocity correlates with liver fibrosis and hepatic venous pressure gradient in adults with advanced liver disease[J]. Biomed Res Int, 2017, 2017:2067479.
|
|
[33] RONOT M, LAMBERT S, ELKRIEF L, et al. Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis[J]. Eur Radiol, 2014, 24 (6) :1394-1402.
|
|
[34] ASRANI SK, TALWALKAR JA, KAMATH PS, et al. Role of magnetic resonance elastography in compensated and decompensated liver disease[J]. J Hepatol, 2014, 60 (5) :934-939.
|
|
[35] ABE K, TAKAHASHI A, IMAIZUMI H, et al. Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease[J]. J Gastroenterol Hepatol, 2018, 33 (3) :733-740.
|
|
[36] SHIN SU, LEE JM, YU MH, et al. Prediction of esophageal varices in patients with cirrhosis:Usefulness of three-dimensional MR elastography with echo-planar imaging technique[J]. Radiology, 2014, 272 (1) :143-153.
|
|
[37] GOH GB, MCCULLOUGH AJ. Natural history nonalcoholic fatty liver disease[J]. Dig Dis Sci, 2016, 61 (5) :1226-1233.
|
|
[38] HU MQ, XU YQ, ZHANG T, et al. Research advances in noninvasive diagnostic methods for nonalcoholic steatohepatitis[J]. J Clin Hepatol, 2017, 33 (12) :2288-2291. (in Chinese) 胡梦琪, 徐有青, 张涛, 等.非酒精性脂肪性肝炎的无创诊断方法[J].临床肝胆病杂志, 2017, 33 (12) :2288-2291.
|
|
[39] SALAMEH N, LARRAT B, ABARCAQUINONES J, et al. Early detection of steatohepatitis in fatty rat liver by using MR elastography[J]. Radiology, 2009, 253 (1) :90-97.
|
|
[40] CHEN J, TALWALKAR JA, YIN M, et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography[J]. Radiology, 2011, 259 (3) :749-756.
|
|
[41] LOOMBA R, WOLFSON T, ANG B, et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease:A prospective study[J]. Hepatology, 2014, 60 (6) :1920-1928.
|
|
[42] LOOMBA R, CUI J, WOLFSON T, et al. Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD:A prospective study[J]. Am J Gastroenterol, 2016, 111 (7) :986-994.
|
|
[43] COSTASILVA L, FEROLLA SM, LIMA AS, et al. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease[J]. Eur J Radiol, 2018, 98:82-89.
|
|
[44] GORDIC S, AYACHE JB, KENNEDY P, et al. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy[J]. Abdom Radiol, 2017, 42 (6) :1685-1694.
|
|
[45] JANG S, LEE JM, LEE DH, et al. Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma[J]. J Magn Reson Imaging, 2017, 45 (6) :1627-1636.
|
|
[46] LOOMBA R, SIRLIN CB, ANG B, et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis:Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial) [J]. Hepatology, 2015, 61 (4) :1239-1250.
|
|
[47] LI B, MIN J, LIANG WR, et al. Use of magnetic resonance elastography for assessing liver functional reserve:A clinical study[J]. World J Gastroenterol, 2015, 21 (24) :7522-7528.
|
|
[48] YIN M, TALWALKAR JA, GLASER KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography[J].Clin Gastroenterol Hepatol, 2007, 5 (10) :1207-1213.
|
|
[49] TALWALKAR JA. Elastography for detecting hepatic fibrosis:Options and considerations[J]. Gastroenterology, 2008, 135 (1) :299-302.
|
|
[50] TAOULI B, EHMAN RL, REEDER SB, et al. Advanced MRI methods for assessment of chronic liver disease[J]. Am J Roentgenol, 2009, 193 (1) :14-27.
|
|
[51] SHARMA P, BANSAL R, MATIN A, et al. Role of transient elastography (fibroscan) in differentiating severe acute hepatitis and acute on chronic liver failure[J]. J Clin Exp Hepatol, 2015, 5 (4) :303-309.
|
|
[52] ICHIKAWA S, MOTOSUGI U, NAKAZAWA T, et al. Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography[J]. J Magn Reson Imaging, 2015, 41 (5) :1203-1208.
|
|
[53] YOSHIMITSU K, MITSUFUJI T, SHINAGAWA Y, et al. MR elastography of the liver at 3. 0 T in diagnosing liver fibrosis grades:Preliminary clinical experience[J]. Eur Radiol, 2016, 26 (3) :656-663.
|
DownLoad: